Rishab Ramapriyan
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
Papers in
- Co-authors
- James W. Welsh (10 shared papers)María Angélica Cortez (8 shared papers)Hari Menon (6 shared papers)Hampartsoum B. Barsoumian (7 shared papers)Vivek Verma (2 shared papers)George A. Călin (2 shared papers)Simone Anfossi (1 shared paper)Maureen Aliru (1 shared paper)
- Journals
- Pharmacology & Therapeutics (3 papers)Neurosurgical FOCUS (2 papers)Nature Communications (1 paper)Clinical Cancer Research (1 paper)Advances in Radiation Oncology (1 paper)
- Partner nations
- United StatesTürkiyeBelgium
In The Last Decade
Rishab Ramapriyan
17 papers receiving 612 citations
Peers
Comparison fields: 5 of 60
- Oncology 287
- Cancer Research 156
- Immunology 145
- Pulmonary and Respiratory Medicine 128
- Genetics 29
Countries citing papers authored by Rishab Ramapriyan
This map shows the geographic impact of Rishab Ramapriyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rishab Ramapriyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rishab Ramapriyan more than expected).
Fields of papers citing papers by Rishab Ramapriyan
This network shows the impact of papers produced by Rishab Ramapriyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rishab Ramapriyan. The network helps show where Rishab Ramapriyan may publish in the future.
Co-authors
The 25 scholars most cited alongside Rishab Ramapriyan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 124 | |
| 2 | 2018 | 120 | |
| 3 | 2019 | 118 | |
| 4 | 2020 | 78 | |
| 5 | 2020 | 73 | |
| 6 | 2020 | 30 | |
| 7 | 2024 | 21 | |
| 8 | 2018 | 21 | |
| 9 | 2023 | 8 | |
| 10 | 2024 | 6 | |
| 11 | 2023 | 5 | |
| 12 | 2024 | 4 | |
| 13 | 2024 | 4 | |
| 14 | 2022 | 3 | |
| 15 | 2019 | 2 | |
| 16 | 2021 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2025 | 0 | |
| 19 | 2025 | 0 | |
| 20 | 2024 | 0 |
About Rishab Ramapriyan
Rishab Ramapriyan is a scholar working on Oncology, Genetics, Molecular Biology, Immunology and Neurology, having authored 20 papers that have together received 619 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (4 papers), Immune cells in cancer (3 papers), Effects of Radiation Exposure (2 papers), Cancer Cells and Metastasis (2 papers), Inflammatory Biomarkers in Disease Prognosis (1 paper) and Advanced Radiotherapy Techniques (1 paper). The work is most often cited by research in Oncology (287 citations), Cancer Research (156 citations), Immunology (145 citations), Pulmonary and Respiratory Medicine (128 citations) and Genetics (29 citations). Rishab Ramapriyan has collaborated with scholars based in United States, Türkiye and Belgium. Frequent co-authors include James W. Welsh, María Angélica Cortez, Hari Menon, Hampartsoum B. Barsoumian, Vivek Verma, George A. Călin, Simone Anfossi, Maureen Aliru, Mauricio S. Caetano and Érika Pereira Zambalde. Their work appears in journals such as Pharmacology & Therapeutics, Neurosurgical FOCUS, Nature Communications, Clinical Cancer Research and Advances in Radiation Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.